ABBV AbbVie Inc.
Healthcare
Price
$247.94
Intrinsic value
$38.58
Buy price
$30.86
Discount
-542.7%
DCF walkthrough
Near-term growth (g1)0.00%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $19,507,000,000.00
- Total debt
- $70,884,999,168.00
- Cash & STI
- $6,568,999,936.00
- Shares out.
- 1,771,000,000
Overvalued [LOW CF reliability]
Intrinsic value$38.58
Buy price (with MOS)$30.86
Current price$247.94
Discount to intrinsic value-542.7%
7-step quality scorecard
ROE quality
HIGH_DISTORTED- Average ROE
- 81.4%
- Current ROE
- 128.7%
- Minimum ROE
- 46.9%
Debt quality
MODERATE- Debt / Equity
- —
Moat proxy
MODERATE_PROXYCash-flow reliability
LOW- Operating CF / Net income
- 3.11x
Technical chart
Confluence: WEAK (1/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(cfCAGR,revenueCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 53.4%
- Public economic interest
- 100.0%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.